Colorectal cancer is one of the most commonly occurring cancers (6.1% of total diagnosed cases and 9.2% of total cancer deaths).91 YB‐1 can induce oxaliplatin resistance by interacting with NONO and RALY in colorectal cancer cells. Here, RALY is linked to cancer.